Bioinformatic analysis showed that the decrease in FUNDC1 was associated with increased ROS signaling and metastasis, particularly in lung cancer, but another study reported elevated FUNDC1 with increased tumor cell proliferation, migration, invasion, and the resulting poor prognosis for breast cancer patients [146,147]. The gene discussed is FUNDC1; the disease is lung carcinoma.